These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 24879062)
1. A comparative study of the effects of inhibitory cytokines on human natural killer cells and the mechanistic features of transforming growth factor-beta. Lee HM; Kim KS; Kim J Cell Immunol; 2014 Jul; 290(1):52-61. PubMed ID: 24879062 [TBL] [Abstract][Full Text] [Related]
2. Role of c-Myb in the regulation of natural killer cell activity. Shin HW; Lee YJ; Kim J Biochem Biophys Res Commun; 2018 Sep; 503(4):2807-2813. PubMed ID: 30103947 [TBL] [Abstract][Full Text] [Related]
3. IL-2/IL-18 prevent the down-modulation of NKG2D by TGF-beta in NK cells via the c-Jun N-terminal kinase (JNK) pathway. Song H; Hur DY; Kim KE; Park H; Kim T; Kim CW; Bang S; Cho DH Cell Immunol; 2006 Jul; 242(1):39-45. PubMed ID: 17070508 [TBL] [Abstract][Full Text] [Related]
4. Unique phenotype of human uterine NK cells and their regulation by endogenous TGF-beta. Eriksson M; Meadows SK; Wira CR; Sentman CL J Leukoc Biol; 2004 Sep; 76(3):667-75. PubMed ID: 15178706 [TBL] [Abstract][Full Text] [Related]
5. Mechanistic studies of transforming growth factor-beta inhibition of IL-2-dependent activation of CD3- large granular lymphocyte functions. Regulation of IL-2R beta (p75) signal transduction. Ortaldo JR; Mason AT; O'Shea JJ; Smyth MJ; Falk LA; Kennedy IC; Longo DL; Ruscetti FW J Immunol; 1991 Jun; 146(11):3791-8. PubMed ID: 1851793 [TBL] [Abstract][Full Text] [Related]
6. MAPK/AP-1-dependent regulation of PAI-1 gene expression by TGF-beta in rat mesangial cells. Guo B; Inoki K; Isono M; Mori H; Kanasaki K; Sugimoto T; Akiba S; Sato T; Yang B; Kikkawa R; Kashiwagi A; Haneda M; Koya D Kidney Int; 2005 Sep; 68(3):972-84. PubMed ID: 16105028 [TBL] [Abstract][Full Text] [Related]
7. Dendritic cell regulation of NK-cell responses involves lymphotoxin-α, IL-12, and TGF-β. Sarhan D; Palma M; Mao Y; Adamson L; Kiessling R; Mellstedt H; Österborg A; Lundqvist A Eur J Immunol; 2015 Jun; 45(6):1783-93. PubMed ID: 25773885 [TBL] [Abstract][Full Text] [Related]
8. TGF-beta inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes. Bright JJ; Sriram S J Immunol; 1998 Aug; 161(4):1772-7. PubMed ID: 9712043 [TBL] [Abstract][Full Text] [Related]
9. CD160-activating NK cell effector functions depend on the phosphatidylinositol 3-kinase recruitment. Rabot M; El Costa H; Polgar B; Marie-Cardine A; Aguerre-Girr M; Barakonyi A; Valitutti S; Bensussan A; Le Bouteiller P Int Immunol; 2007 Apr; 19(4):401-9. PubMed ID: 17307798 [TBL] [Abstract][Full Text] [Related]
10. TGF-beta does not inhibit IL-12- and IL-2-induced activation of Janus kinases and STATs. Sudarshan C; Galon J; Zhou Y; O'Shea JJ J Immunol; 1999 Mar; 162(5):2974-81. PubMed ID: 10072548 [TBL] [Abstract][Full Text] [Related]
11. Differential regulation of interleukin-12- and interleukin-15-induced natural killer cell activation by interleukin-4. Salvucci O; Mami-Chouaib F; Moreau JL; Thèze J; Chehimi J; Chouaib S Eur J Immunol; 1996 Nov; 26(11):2736-41. PubMed ID: 8921963 [TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways. Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969 [TBL] [Abstract][Full Text] [Related]
13. Enhancement of cytokine production and AP-1 transcriptional activity in T cells by thalidomide-related immunomodulatory drugs. Schafer PH; Gandhi AK; Loveland MA; Chen RS; Man HW; Schnetkamp PP; Wolbring G; Govinda S; Corral LG; Payvandi F; Muller GW; Stirling DI J Pharmacol Exp Ther; 2003 Jun; 305(3):1222-32. PubMed ID: 12649301 [TBL] [Abstract][Full Text] [Related]
14. Differential utilization of Janus kinase-signal transducer activator of transcription signaling pathways in the stimulation of human natural killer cells by IL-2, IL-12, and IFN-alpha. Yu CR; Lin JX; Fink DW; Akira S; Bloom ET; Yamauchi A J Immunol; 1996 Jul; 157(1):126-37. PubMed ID: 8683106 [TBL] [Abstract][Full Text] [Related]
15. Colocalization of the IL-12 receptor and FcgammaRIIIa to natural killer cell lipid rafts leads to activation of ERK and enhanced production of interferon-gamma. Kondadasula SV; Roda JM; Parihar R; Yu J; Lehman A; Caligiuri MA; Tridandapani S; Burry RW; Carson WE Blood; 2008 Apr; 111(8):4173-83. PubMed ID: 18174382 [TBL] [Abstract][Full Text] [Related]
16. Activated alpha 2-macroglobulin reverses the immunosuppressive activity in human breast cancer cell-conditioned medium by selectively neutralizing transforming growth factor-beta in the presence of interleukin-2. Harthun NL; Weaver AM; Brinckerhoff LH; Deacon DH; Gonias SL; Slingluff CL J Immunother; 1998 Mar; 21(2):85-94. PubMed ID: 9551359 [TBL] [Abstract][Full Text] [Related]
17. TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway. Viel S; Marçais A; Guimaraes FS; Loftus R; Rabilloud J; Grau M; Degouve S; Djebali S; Sanlaville A; Charrier E; Bienvenu J; Marie JC; Caux C; Marvel J; Town L; Huntington ND; Bartholin L; Finlay D; Smyth MJ; Walzer T Sci Signal; 2016 Feb; 9(415):ra19. PubMed ID: 26884601 [TBL] [Abstract][Full Text] [Related]
18. Differential regulation of the Janus kinase-STAT pathway and biologic function of IL-13 in primary human NK and T cells: a comparative study with IL-4. Yu CR; Kirken RA; Malabarba MG; Young HA; Ortaldo JR J Immunol; 1998 Jul; 161(1):218-27. PubMed ID: 9647227 [TBL] [Abstract][Full Text] [Related]